Elorza, Anabel L.

HRN: 06-32-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2023
CO-AMOXICLAV 625MG (TAB)
02/05/2023
02/11/2023
ORAL
625mg
TID
Acute Tonsillopharyngitis
Waiting Final Action 
02/05/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/05/2023
02/11/2023
IV
600mg
Q6
Acute Tonsillopharyngitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: